Skip to main content
. 2016 May 26;7(26):40387–40397. doi: 10.18632/oncotarget.9617

Figure 5. A schematic drawing of Integrin αvβ3/PI3K/Akt/GSK3β/β-catenin axis for microenvironment mediated TKI insensitivity in FLT3-ITD AML cells.

Figure 5